Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Afghanistan
Sri Lanka
G7 Summit
United States of America
COVID-19
Russia-Ukraine crisis
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
World

US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use

US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
Written by Ramya Patelkhana
Dec 11, 2020, 06:43 pm 3 min read
US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
Credits:

A panel of expert advisors to the US Food and Drug Administration (FDA) has granted the emergency use authorization (EUA) to the COVID-19 vaccine developed by Pfizer and BioNTech. The authorization by the FDA's vaccine advisors reportedly came after a 9-hour-long debate on the vaccine's safety and efficacy data. To recall, Pfizer earlier said its vaccine was 95% effective in preventing COVID-19. Here's more.

Details
17 experts voted in favor of granting EUA, 4 against

According to reports, 17 of the advisors in the FDA expert panel voted in favor of granting EUA to Pfizer-BioNTech's COVID-19 vaccine, while four voted against and one abstained. With this approval, the US - which continues to be the world's worst-affected country by the pandemic - is just a step away from launching a mass immunization drive to fight the novel coronavirus disease.

Quote
The one question expert panel was tasked with answering

The panel of outside advisors to the FDA was reportedly tasked with answering one major question: "Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 vaccine outweigh its risk for use in individuals 16 years of age and older?"

Statement
'Appears to be our way out of this awful mess'

Dr. Paul Offit, Director of Vaccine Education Center at Children's Hospital of Philadelphia and a member of the FDA expert committee—who voted in favor of EUA—told CNN's Wolf Blitzer: "The question is never when you know everything." "It's when you know enough...I think we know enough now to say that this appears to be our way out of this awful, awful mess," he added.

Emergency use
Earlier, UK gave emergency approval to Pfizer-BioNTech's vaccine

The US so far recorded over 16 million COVID-19 cases and nearly 300,000 deaths. However, with the EUA to the Pfizer-BioNTech's vaccine candidate, the spread of the coronavirus and surge in deaths are expected to slow down. To recall, on December 2, the United Kingdom gave emergency approval to Pfizer-BioNTech's COVID-19 vaccine, becoming the first Western country to allow mass immunization against the disease.

Vaccination
FDA is expected to authorize the vaccine within days

Reports say that shots could be administered within days in the US, most importantly depending on how quickly the FDA authorizes the vaccine. The agency is expected to sign off the recommendation of the independent expert panel within days. Notably, priority will be given to healthcare workers and nursing home residents who will receive the first shots in early-2021.

Statement
Time of great urgency, says FDA Commissioner

"In this time of great urgency, FDA staff feel the responsibility to move as quickly as possible through the review process," stated FDA Commissioner Dr. Stephen Hahn. "However, they know...they must carry out their mandate to protect the public health and to ensure that any authorized vaccine meets our rigorous standards for safety and effectiveness that...American people have come to expect," he added.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Ramya Patelkhana
Ramya Patelkhana
Mail
Ramya Patelkhana is a senior editor at NewsBytes. She has nearly seven years of experience in digital journalism and has previously worked with India News and Authint Media. She has a Bachelor's degree in Journalism and Mass Communication from the IK Gujral Punjab Technical University, Kapurthala, and an advanced diploma in Media Studies from IPW, New Delhi.
Latest
Related
Latest
Rishabh Pant gets past 2,000 Test runs: Key stats
Rishabh Pant gets past 2,000 Test runs: Key stats Sports
2022 TVS Radeon goes official in India: Check price, features
2022 TVS Radeon goes official in India: Check price, features Auto
This is not Sena CM: Thackeray removes Shinde from party
This is not Sena CM: Thackeray removes Shinde from party Politics
5 iconic accommodations in London
5 iconic accommodations in London Lifestyle
Celebrities likely to guest on 'Koffee with Karan 7'
Celebrities likely to guest on 'Koffee with Karan 7' Entertainment
Related
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity' World
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022